Regeneron Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €15.45B +6.2% €5.32B +8.0% 34.4% +0.0056 pp €5.27B -9.0% 34.1% -0.057 pp
    (estimated) €14.54B +6.6% €4.93B +7.2% 33.9% +0.0019 pp €5.79B +12.8% 39.8% +0.022 pp
    (estimated) €13.64B +10.1% €4.60B +18.7% 33.7% +0.024 pp €5.13B +21.2% 37.6% +0.034 pp
    (estimated) €12.38B +4.6% €3.87B +3.1% 31.3% -0.0045 pp €4.23B -12.7% 34.2% -0.068 pp
    (estimated) €11.84B -2.3% €3.75B -0.2% 31.7% +0.0065 pp €4.85B +9.8% 40.9% +0.045 pp
    €12.11B +8.3% €3.76B +11.6% 31.1% +0.0093 pp €4.42B -6.2% 36.4% -0.056 pp
    €11.19B +7.8% €3.37B -8.9% 30.1% -0.055 pp €4.71B -1.5% 42.1% -0.040 pp
    €10.38B -24.3% €3.70B -46.3% 35.6% -0.15 pp €4.78B -26.6% 46.0% -0.014 pp
    €13.71B +89.1% €6.89B +129.9% 50.2% +0.089 pp €6.51B +136.1% 47.5% +0.094 pp
    €7.25B +8.1% €3.00B +66.0% 41.3% +0.14 pp €2.76B +13.0% 38.0% +0.017 pp
    €6.71B +17.2% €1.80B -13.4% 26.9% -0.095 pp €2.44B +10.9% 36.4% -0.021 pp
    €5.72B +14.3% €2.08B +104.0% 36.4% +0.16 pp €2.20B +63.2% 38.4% +0.12 pp
    €5.01B +20.8% €1.02B +33.8% 20.4% +0.020 pp €1.35B -20.9% 26.9% -0.14 pp
    €4.15B +18.4% €763.84M +40.8% 18.4% +0.029 pp €1.70B -0.5% 41.1% -0.078 pp
    €3.50B +45.5% €542.52M +82.7% 15.5% +0.032 pp €1.71B +85.1% 48.9% +0.10 pp
    €2.40B +34.0% €296.89M -18.0% 12.3% -0.078 pp €925.83M +45.7% 38.5% +0.031 pp
    €1.80B +52.7% €361.96M -43.4% 20.2% -0.34 pp €635.38M -3,046.9% 35.4% +0.37 pp
    €1.18B +209.2% €639.94M -438.3% 54.4% +1.0 pp -€21.56M -70.1% -1.8% +0.17 pp
    €380.27M -2.9% -€189.15M +112.3% -49.7% -0.27 pp -€72.04M -143.1% -18.9% -0.62 pp
    €391.57M +21.0% -€89.11M +54.0% -22.8% -0.049 pp €167.21M +681.4% 42.7% +0.36 pp
    €323.50M +59.1% -€57.86M -18.0% -17.9% +0.17 pp €21.40M -146.3% 6.6% +0.29 pp
    €203.39M +90.7% -€70.55M -21.7% -34.7% +0.50 pp -€46.25M -218.4% -22.7% -0.59 pp
    €106.64M +97.1% -€90.07M +3.2% -84.5% +0.77 pp €39.08M +77.0% 36.6% -0.042 pp
    €54.12M -4.1% -€87.29M +7.2% -161.3% -0.17 pp €22.08M -202.2% 40.8% +0.79 pp
    €56.46M -62.0% -€81.41M -328.9% -144.2% -1.7 pp -€21.61M +136.0% -38.3% -0.32 pp
    €148.43M +202.7% €35.57M -138.8% 24.0% +2.1 pp -€9.16M -145.6% -6.2% -0.47 pp
    €49.04M +161.5% -€91.66M -13.6% -186.9% +3.8 pp €20.06M -130.9% 40.9% +3.9 pp
    €18.75M +0.1% -€106.09M +63.3% -565.7% -2.2 pp -€64.95M +55.1% -346.3% -1.2 pp
    €18.74M -62.9% -€64.98M +228.1% -346.7% -3.1 pp -€41.88M +129.3% -223.4% -1.9 pp
    €50.56M +71.8% -€19.80M +0.5% -39.2% +0.28 pp -€18.27M +164.4% -36.1% -0.13 pp
    €29.43M -9.7% -€19.70M +168.6% -67.0% -0.44 pp -€6.91M +12.5% -23.5% -0.046 pp
    €32.58M +15.4% -€7.34M -25.9% -22.5% +0.13 pp -€6.14M +80.0% -18.8% -0.068 pp
    €28.23M +37.3% -€9.89M -64.2% -35.0% +0.99 pp -€3.41M -65.8% -12.1% +0.36 pp
    €20.56M -12.0% -€27.64M +37.9% -134.4% -0.49 pp -€9.98M -21.5% -48.5% +0.058 pp
    €23.37M +18.1% -€20.04M -23.5% -85.8% +0.47 pp -€12.71M +9.6% -54.4% +0.042 pp
    €19.79M +118.9% -€26.19M -23.1% -132.3% +2.4 pp -€11.60M -31.7% -58.6% +1.3 pp
    €9.04M -7.8% -€34.03M +108.9% -376.4% -2.1 pp -€16.97M +31.8% -187.7% -0.56 pp
    €9.81M +57.5% -€16.29M +324.4% -166.1% -1.0 pp -€12.88M +160.3% -131.3% -0.52 pp
    €6.23M -€3.84M -61.6% -€4.95M -79.5%

    Notifications